German IPOs off to poor start as AlzChem Pulls its €174m deal

By Aidan Gregory
07 Feb 2017

AlzChem, the German niche chemicals producer, has postponed its €174m Frankfurt IPO, blaming difficult market conditions.

The bookbuild, which had Société Générale and Baader Bank as global co-ordinators, was launched on Tuesday, January 27, with a price range of €20-€27 a share. AlzChem was scheduled to price its IPO on Wednesday.

With up to 8.1m shares on sale, the deal would have been worth €162m-€219.5m ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.